Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Recruiting

Phase 2

Chemotherapy With or Without Immunotherapy for Peritoneal MesotheliomaChemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05001880

Conditions

Peritoneal Malignant Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Bevacizumab

Biospecimen Collection

Carboplatin

Computed Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-03-25.